BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34420860)

  • 41. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
    Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
    Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
    Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
    Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brachytherapy for Buccal Cancer: From Conventional Low Dose Rate (LDR) or Mold Technique to High Dose Rate Interstitial Brachytherapy (HDR-ISBT).
    Kotsuma T; Yamazaki H; Masui K; Yoshida K; Shimizutani K; Akiyama H; Murakami S; Isohashi F; Yoshioka Y; Ogawa K; Tanaka E
    Anticancer Res; 2017 Dec; 37(12):6887-6892. PubMed ID: 29187469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications.
    Tyree WC; Cardenes H; Randall M; Papiez L
    Int J Gynecol Cancer; 2002; 12(1):27-31. PubMed ID: 11860533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fractionated high dose-rate versus low dose-rate regimens for intracavitary brachytherapy of the cervix: equivalent regimens for combined brachytherapy and external irradiation.
    Brenner DJ; Huang Y; Hall EJ
    Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1415-23. PubMed ID: 1938549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time-driven activity-based costing of low-dose-rate and high-dose-rate brachytherapy for low-risk prostate cancer.
    Ilg AM; Laviana AA; Kamrava M; Veruttipong D; Steinberg M; Park SJ; Burke MA; Niedzwiecki D; Kupelian PA; Saigal C
    Brachytherapy; 2016; 15(6):760-767. PubMed ID: 27720202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High dose rate versus low dose rate interstitial radiotherapy for carcinoma of the floor of mouth.
    Inoue T; Inoue T; Yamazaki H; Koizumi M; Kagawa K; Yoshida K; Shiomi H; Imai A; Shimizutani K; Tanaka E; Nose T; Teshima T; Furukawa S; Fuchihata H
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):53-8. PubMed ID: 9588917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Chao C; Erickson B; Fowler J; Gupta N; Martinez A; Thomadsen B;
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):33-48. PubMed ID: 11777620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma.
    Sarkaria JN; Petereit DG; Stitt JA; Hartman T; Chappell R; Thomadsen BR; Buchler DA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):75-82; discussion 247. PubMed ID: 8083131
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy.
    Tward JD; Jarosek S; Chu H; Thorpe C; Shrieve DC; Elliott S
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1443-1453. PubMed ID: 27325475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
    Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States.
    Nag S; Orton C; Young D; Erickson B
    Gynecol Oncol; 1999 Apr; 73(1):111-8. PubMed ID: 10094890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A population-based study of cervix cancer: incidence, management and outcome in the Canadian province of Saskatchewan.
    Mahmud A; Brydon B; Tonita J; Hanna TP; Schmidt M; Tai P
    Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):691-5. PubMed ID: 21646003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radical radiation therapy for adenocarcinoma of the uterine cervix.
    Toita T; Takizawa Y; Nakano M; Sueyama H; Kushi A; Kakihana Y; Ogawa K; Hara R; Higashi M; Sakumoto K
    Strahlenther Onkol; 1994 May; 170(5):277-80. PubMed ID: 8197550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical evaluation based on cost-effectiveness].
    Inoue T; Inoue T
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):13-9. PubMed ID: 9464324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3T multiparametric MRI-guided high-dose-rate combined intracavitary and interstitial adaptive brachytherapy for the treatment of cervical cancer with a novel split-ring applicator.
    Fredman E; Traughber B; Podder T; Colussi V; Zheng Y; Russo S; Herrmann K; Paspulati R; Waggoner S; Zanotti K; Nagel C; Nakayama J; Machtay M; Ellis R
    Brachytherapy; 2018; 17(2):334-344. PubMed ID: 29097137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost minimization analysis of high-dose-rate versus low-dose-rate brachytherapy in endometrial cancer. Gynecology Tumor Group.
    Pinilla J
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):87-90. PubMed ID: 9747824
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
    King CR
    Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.